PTEN and neoplasm: In primary glioma tissues, levels of PD-L1 protein correlated with PTEN loss, and tumor-specific T-cells lysed human glioma targets expressing wild-type PTEN more effectively than those expressing mutant PTEN, suggesting that loss of PTEN is associated with high levels of PD-L1 and immune evasion and immunoresistance [29-31].